Natural Product: NPC214756

Natural Product IDNPC214756
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Methyl 11-Oxo-Oleanoloate
IUPAC Name methyl (4aS,6aR,6aS,6bR,8aR,10S,12aS,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-4a-carboxylate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL3109256
PubChem CID 21723770
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey WWQDFVOIJWUDSM-CYVYTNFQSA-N
Standard InCHI InChI=1S/C31H48O4/c1-26(2)13-15-31(25(34)35-8)16-14-29(6)19(20(31)18-26)17-21(32)24-28(5)11-10-23(33)27(3,4)22(28)9-12-30(24,29)7/h17,20,22-24,33H,9-16,18H2,1-8H3/t20-,22-,23-,24+,28-,29+,30+,31-/m0/s1
SMILES CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@@H](C(C)(C)[C@@H]5CC[C@@]34C)O)[C@@H]2C1)C(=O)OC

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   484.36 Volume:   529.201
?
Van der Waals volume.
Dense:   0.915 LogP:   3.543
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.505
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.789
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   28.0
TPSA:   63.6
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   1.0 Rings:   5.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.431 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.678 Fsp3:   0.871
MCE-18:   106.207
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.65 Fluc inhibitor:   0.019
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.1
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.321 Promiscuous compounds:   0.33

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.293 MDCK Permeability:   -4.981
Pgp-inhibitor:   0.738 Pgp-substrate:   0.085
PAMPA:   0.96
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.012
20% Bioavailability (F20%):   0.832 30% Bioavailability (F30%):   0.699
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.844 MRP1:   0.915
Plasma Protein Binding (PPB):   96.871% Volume Distribution (VD):   0.058
Fu: 4.024%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.998 BCRP inhibitor:   0.741
BSEP inhibitor:   0.988

ADMET: Metabolism

CYP1A2-inhibitor:   0.004 CYP1A2-substrate:   0.758
CYP2C19-inhibitor:   0.998 CYP2C19-substrate:   0.989
CYP2C9-inhibitor:   0.011 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.008
CYP3A4-inhibitor:   0.546 CYP3A4-substrate:   0.949
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.676
HLM stability:   0.789
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.581 Half-life (T1/2):  0.448

ADMET: Toxicity

hERG Blockers:  0.107 hERG Blockers (10um):  0.237
Human Hepatotoxicity (H-HT):  0.842 Drug-induced Liver Injury (DILI):  0.42
AMES Toxicity:  0.359 Rat Oral Acute Toxicity:  0.551
Maximum Recommended Daily Dose:  0.761 Skin Sensitization:  0.902
Carcinogencity:  0.886 Eye Corrosion:  0.021
Eye Irritation:  0.655 Respiratory Toxicity:  0.934
Drug-induced Neurotoxicity:  0.157 Ototoxicity:  0.433
Hematotoxicity:  0.449 Drug-induced Nephrotoxicity:  0.8
Genotoxicity:  0.667 RPMI-8226 Immunitoxicity:  0.055
A549 Cytotoxicity:  0.371 Hek293 Cytotoxicity:  0.336
BCF:   2.15
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.547
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.95
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.45
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2117 Plakortis nigra Species Plakinidae Eukaryota n.a. Palauan n.a. PMID[12350142]
NPO2117 Plakortis nigra Species Plakinidae Eukaryota n.a. Indo-Pacific n.a. PMID[15387674]
NPO2543 Anthopleura pacifica Species Actiniidae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO2117 Plakortis nigra Species Plakinidae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO28655 Perovskia angustifolia Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO13905 Galaxaura filamentosa Species Galaxauraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO2117 Plakortis nigra Species Plakinidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO22067 Pogostemon stellatus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO2543 Anthopleura pacifica Species Actiniidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13905 Galaxaura filamentosa Species Galaxauraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28655 Perovskia angustifolia Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1218 Individual protein Carbonic anhydrase II Bos taurus Ki > 50000.0 nM PMID[25147151]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell line A2780 Homo sapiens Activity = 34.13 % PMID[24361521]
NPT179 Cell line A2780 Homo sapiens Activity = 33.08 % PMID[24361521]
NPT179 Cell line A2780 Homo sapiens Activity = 29.68 % PMID[24361521]
NPT179 Cell line A2780 Homo sapiens Activity = 3.11 % PMID[24361521]
NPT179 Cell line A2780 Homo sapiens Activity > 50.0 % PMID[24361521]
NPT886 Cell line NIH3T3 Mus musculus IC50 = 24800.0 nM PMID[24361521]
NPT83 Cell line MCF7 Homo sapiens IC50 = 21300.0 nM PMID[24361521]
NPT139 Cell line HT-29 Homo sapiens IC50 = 18500.0 nM PMID[24361521]
NPT81 Cell line A549 Homo sapiens IC50 = 15100.0 nM PMID[24361521]
NPT179 Cell line A2780 Homo sapiens IC50 = 6600.0 nM PMID[24361521]
NPT1215 Cell line 8505C Homo sapiens IC50 = 13000.0 nM PMID[24361521]
NPT139 Cell line HT-29 Homo sapiens EC50 = 27620.0 nM PMID[26177446]
NPT83 Cell line MCF7 Homo sapiens EC50 = 28690.0 nM PMID[26177446]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 15600.0 nM PMID[24361521]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. EC50 > 30000.0 nM PMID[26177446]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC214756 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.746 Intermediate Similarity NPC295643
0.7188 Intermediate Similarity NPC272075
0.7143 Intermediate Similarity NPC246708
0.6308 Remote Similarity NPC602872
0.6143 Remote Similarity NPC98874
0.6111 Remote Similarity NPC471966
0.6056 Remote Similarity NPC4036
0.6056 Remote Similarity NPC65120
0.6056 Remote Similarity NPC145067
0.6056 Remote Similarity NPC233455
0.6056 Remote Similarity NPC158030
0.5821 Remote Similarity NPC470588
0.5797 Remote Similarity NPC479748
0.5735 Remote Similarity NPC480944
0.5714 Remote Similarity NPC136313
0.5692 Remote Similarity NPC190035
0.5634 Remote Similarity NPC488519
0.5441 Remote Similarity NPC235341
0.5405 Remote Similarity NPC610635
0.5375 Remote Similarity NPC167383
0.5303 Remote Similarity NPC290598
0.5303 Remote Similarity NPC30590
0.5286 Remote Similarity NPC267517
0.5211 Remote Similarity NPC40552
0.5072 Remote Similarity NPC101475

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC214756 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6056 Remote Similarity NPD7515 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data